Pilgrim's Pride (PPC) Faces Earnings Doubts, Is The Stock A Bargain?

Pilgrim's Pride (PPC) is back in focus after recent analyst commentary highlighted expectations for a significant year-over-year earnings decline, along with a Zacks Rank shift to #5 (Strong Sell) that signals growing investor caution.

See our latest analysis for Pilgrim's Pride.

The recent downgrade and earnings concerns come after a weak stretch for Pilgrim's Pride, with the share price down 21.74% over 90 days and the year-to-date share price return down 30.47%. The 3-year total shareholder return of 60.56% contrasts with the 1-year total shareholder return decline of 37.81%, suggesting longer-term holders sit on gains even as recent momentum has clearly faded.

If this kind of earnings-driven volatility has you thinking about where else capital could go to work, it may be worth scanning for other ideas in areas like 20 top founder-led companies

So with Pilgrim's Pride trading at a discount to the average analyst price target and showing an intrinsic discount on some models, is the recent weakness setting up a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 29.4% Undervalued

At a last close of $27.72 versus a fair value narrative of $39.25, Pilgrim's Pride is framed as materially discounted, with that gap hinging on measured growth and modest margin pressure rather than aggressive forecasts.

The company and the broader industry are benefiting from robust growth in global chicken demand, both due to expanding middle classes in emerging markets and the growing affordability gap between chicken and other proteins like beef and pork. If investors are overestimating the durability or pace of this demand, for instance by overlooking potential substitution pressure from alternative proteins or cyclical demand slowdowns, it could result in unrealistically high revenue growth expectations.

Read the complete narrative.

Want to see what underpins that gap between price and fair value? The narrative leans on steady top line growth, slightly slimmer margins and a future earnings multiple that still sits below today’s sector yardstick.

The valuation work behind this narrative applies a 7.1% discount rate to Pilgrim's Pride, modest revenue growth expectations and slightly lower profit margins over time, then looks at what P/E multiple would need to apply on those future earnings to justify $39.25 per share today. It effectively asks whether the market is pricing Pilgrim's Pride as if current profitability pressures will linger longer than analysts expect or whether more stable cash flows from its global, multi protein footprint could support a higher value than the current share price implies.

Result: Fair Value of $39.25 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Pilgrim's Pride still faces risks from input cost volatility and rising labor and regulatory expenses, which could pressure margins and challenge the undervaluation story.

Find out about the key risks to this Pilgrim's Pride narrative.

Next Steps

With mixed signals around Pilgrim's Pride and its valuation, do you want to rely on headlines or check the balance of risks and rewards yourself? You can take a closer look at the full breakdown of 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond Pilgrim's Pride?

If Pilgrim's Pride has you reassessing where your next dollar goes, do not stop here. Fresh ideas from other sectors could make a real difference.

• Spot potential turnaround stories early by scanning 24 elite penny stocks with strong financials that pair smaller market caps with stronger balance sheets and business fundamentals than many investors expect.
• Zero in on quality at a discount by reviewing the 44 high quality undervalued stocks that combine solid cash generation with healthier financial profiles than their current prices suggest.
• Prioritize resilience by checking the 67 resilient stocks with low risk scores that screen for companies with steadier earnings profiles and lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com